VaxGen’s Anthrax Vaccine Clinical Trial Delayed
VaxGen is currently on a clinical hold for it’s anthrax vaccine.
Next Clinical Trial of VaxGen’s Anthrax Vaccine Delayed: Financial News - Yahoo! Finance:
seems there may be stability problems with the proposed clinical trial vaccine product. The data VaxGen submitted to the FDA was insufficient to determine if the product is stable enough to resume clinical trials. The FDA expressed concern about the potency of the vaccine declining during the trial and giving results that are not inconclusive.
This is not an uncommon occurrence for vaccines and so really isn’t a negative. I’m sure they will be able to overcome this and get the trials started soon.
Technorati Tags: anthrax, vaccine, VaxGen
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
